Background First-line chemotherapy for advanced esophageal squamous-cell carcinoma results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival benefit over chemotherapy in previously treated patients with advanced esophageal squamous-cell carcinoma.Methods In this open-...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!